CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy

The advent of engineered T cells as a form of immunotherapy marks the beginning of a new era in medicine, providing a transformative way to combat complex diseases such as cancer. Following FDA approval of CAR T cells directed against the CD19 protein for the treatment of acute lymphoblastic leukemi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hum Vaccin Immunother
Hlavní autoři: Salas-Mckee, January, Kong, Weimin, Gladney, Whitney L., Jadlowsky, Julie K., Plesa, Gabriela, Davis, Megan M., Fraietta, Joseph A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2019
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6605860/
https://ncbi.nlm.nih.gov/pubmed/30735463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1571893
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky